Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis. | Hepatol Commun | 2025 | 41021273 | PubTator, text mining | PubMed |
| Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine. | Cancer Med | 2025 | 40948290 | PubTator, text mining | PubMed |
| First Report of Living Donor Liver Transplantation for NR1H4 Disease. | Pediatr Transplant | 2025 | 40947515 | PubTator, text mining | PubMed |
| Resident and faculty expectations for resident PGY performance for laparoscopic cholecystectomy. | Surg Open Sci | 2025 | 40933468 | PubTator, text mining | PubMed |
| Improving resident physicians' knowledge of the ABCDEF bundle through a multimodal teaching intervention. | Int J Med Educ | 2025 | 40888620 | PubTator, text mining | PubMed |
| Exome Sequencing in Adults with Unexplained Liver Disease: Diagnostic Yield and Clinical Impact. | Diagnostics (Basel) | 2025 | 40870862 | PubTator, text mining | PubMed |
| A Rare ABCB5 Variant in a Familial Case of Intrahepatic Cholestasis of Pregnancy: A Potential Novel Genetic Contributor. | J Clin Med | 2025 | 40869443 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in Mediating Signaling in Biliary Epithelial Cell Activation and Cholangiopathies. | Cells | 2025 | 40862753 | PubTator, text mining | PubMed |
| Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice. | Hepatol Commun | 2025 | 40857400 | PubTator, text mining | PubMed |
| Elafibranor for primary biliary cholangitis: a dual PPAR agonist changing the treatment landscape. | Ann Med Surg (Lond) | 2025 | 40851978 | PubTator, text mining | PubMed |
| Genetic Variants Affect Distinct Metabolic Pathways in Pediatric Multisystem Inflammatory Syndrome and Severe COVID-19. | J Med Virol | 2025 | 40817859 | PubTator, text mining | PubMed |
| PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3. | Cell Death Dis | 2025 | 40730548 | PubTator, text mining | PubMed |
| One Family with Cholestasis: The Twisted Road to the Diagnosis of Pfic 3-Three Case Reports. | Reports (MDPI) | 2025 | 40729246 | PubTator, text mining | PubMed |
| Genetic Variants and Long-Term Outcomes in Korean Children with Progressive Familial Intrahepatic Cholestasis. | Pediatr Gastroenterol Hepatol Nutr | 2025 | 40697762 | PubTator, text mining | PubMed |
| Assessing the effect of composted cyclosporin A fermentation residue as organic fertilizer: Focus on soil fertility and antibiotic resistance. | J Environ Sci (China) | 2025 | 40602925 | PubTator, text mining | PubMed |
| Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 -/- mice and human cholangiocarcinoma tumorigenesis. | Hepatology | 2025 | 40601305 | PubTator, text mining | PubMed |
| Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine. | Int J Mol Sci | 2025 | 40565081 | PubTator, text mining | PubMed |
| Molecular Advances in Cholestatic Liver Diseases. | Adv Anat Pathol | 2025 | 40530431 | PubTator, text mining | PubMed |
| Ion Channel-Extracellular Matrix Interplay in Colorectal Cancer: A Network-Based Approach to Tumor Microenvironment Remodeling. | Int J Mol Sci | 2025 | 40507957 | PubTator, text mining | PubMed |
| Generation of an iPSC line (DPNJMUi002-A) from a progressive familial intrahepatic cholestasis 3 (PFIC3) patient with a heterozygous mutation in the ABCB4 gene. | Stem Cell Res | 2025 | 40505422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=4